Insider trade

LeMaitre Vascular (LMAT)Director sold ~$235K

Bridget A Ross, Director at LeMaitre Vascular, sold ~$235K of LeMaitre Vascular shares.

~$235K
Approx. value · 2,500 sh @ $94.00
2,916
Holds after · shares reported
Traded
Aug 8, 2025
Filed
Aug 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 6, 2025InsiderCEO sold ~$9.35M of LMAT shares in the open market
  2. Aug 8, 2025 · this disclosureInsiderDirector sold ~$235K of LMAT shares in the open market

What came next

  1. Aug 8, 2025InsiderDirector sold ~$88K of LMAT shares in the open market
  2. Aug 11, 2025Insider · 2 peopleInsiders: 5 sales (~$1.6M)
  3. Aug 12, 2025InsiderDirector sold ~$91K of LMAT shares in the open market
  4. Oct 11, 2025Federal contract · $24K obligatedDepartment of Veterans Affairs awarded LEMAITRE VASCULAR INC: $24K obligated to date
  5. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for LeMaitre Vascular

For LeMaitre Vascular, OQRO holds 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LMAT page.

Other recent filings by Bridget A Ross, Director

The full history of Bridget A Ross, Director is on the profile page.

How this filing works

Other disclosures at LeMaitre Vascular

Everything OQRO holds on this company is on its LMAT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data